2019
DOI: 10.1016/j.pdpdt.2019.02.020
|View full text |Cite
|
Sign up to set email alerts
|

Acanthopanacis Cortex extract: A novel photosensitizer for head and neck squamous cell carcinoma therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 36 publications
0
4
0
Order By: Relevance
“…Nevertheless, the search for new photosensitizers is also an active target for the development of PDT. Several works have reported the use of new compounds as promising photosensitizers [ 162 , 163 , 164 , 165 , 166 , 167 , 168 , 169 , 170 ]. From synthesized compounds based on previous structures to entirely new compounds, the research is in continuously update.…”
Section: Photodynamic Therapymentioning
confidence: 99%
See 1 more Smart Citation
“…Nevertheless, the search for new photosensitizers is also an active target for the development of PDT. Several works have reported the use of new compounds as promising photosensitizers [ 162 , 163 , 164 , 165 , 166 , 167 , 168 , 169 , 170 ]. From synthesized compounds based on previous structures to entirely new compounds, the research is in continuously update.…”
Section: Photodynamic Therapymentioning
confidence: 99%
“…Shi et al have shown the potential use of traditional plants extracts for PDT in the treatment of head and neck squamous cell carcinoma [ 163 ]. From the initial 289 plant extracts, 13 showed high fluorescence properties and were screened for their photo-physical characteristics.…”
Section: Photodynamic Therapymentioning
confidence: 99%
“…Few fluorescent products have previously been isolated from plants for cellular imaging [ 15 , 16 ]. In our previous studies, we reported that photosensitizers could be extracted from traditional plants and used for photodynamic treatment [ 17 , 18 ]. After treating with photosensitizers, fluorescence was identified around the nucleus where mitochondria are located.…”
Section: Introductionmentioning
confidence: 99%
“…Currently, only a limited number of PSs are medically approved, most of which are commercially available in small amounts, and in many instances, only a few of them benefit patients entirely in clinical practice. In addition, the practical application of commonly used photophrin related PSs is limited by their slow elimination from the body, consequently resulting in adverse effects such as skin photosensitivity which may persist for weeks after the commencement of the treatment (Shi et al, 2019;Hu et al, 2020).…”
Section: Introductionmentioning
confidence: 99%